Teladoc Health (NYSE:TDOC) Hits New 1-Year Low – Should You Sell?

Shares of Teladoc Health, Inc. (NYSE:TDOC) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $6.01 and last traded at $6.1150, with a volume of 2542150 shares trading hands. The stock had previously closed at $6.29.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on the company. Citigroup cut their price objective on Teladoc Health from $10.00 to $9.00 and set a “neutral” rating for the company in a research report on Friday, January 9th. Weiss Ratings reissued a “sell (e+)” rating on shares of Teladoc Health in a research report on Monday, December 29th. Barclays assumed coverage on shares of Teladoc Health in a research note on Tuesday, December 9th. They issued an “equal weight” rating and a $8.50 price objective on the stock. Evercore ISI reduced their price target on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a report on Thursday, October 30th. Finally, BMO Capital Markets assumed coverage on shares of Teladoc Health in a research report on Thursday, November 13th. They issued a “market perform” rating and a $8.00 price target on the stock. Three research analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $9.12.

Teladoc Health Stock Performance

The firm has a 50 day moving average price of $7.15 and a two-hundred day moving average price of $7.65. The company has a market capitalization of $1.06 billion, a P/E ratio of -4.64 and a beta of 2.04. The company has a debt-to-equity ratio of 0.71, a quick ratio of 2.60 and a current ratio of 2.70.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.05. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The company had revenue of $626.44 million during the quarter, compared to analysts’ expectations of $625.66 million. During the same period last year, the business earned ($0.19) earnings per share. The business’s revenue was down 2.2% on a year-over-year basis. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. On average, research analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Carlos Nueno sold 3,897 shares of the firm’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total transaction of $29,188.53. Following the completion of the sale, the insider directly owned 27,175 shares of the company’s stock, valued at $203,540.75. This trade represents a 12.54% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Adam C. Vandervoort sold 5,720 shares of the business’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total value of $42,842.80. Following the completion of the transaction, the insider directly owned 80,732 shares in the company, valued at approximately $604,682.68. This represents a 6.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 33,288 shares of company stock worth $251,684. Corporate insiders own 0.58% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in TDOC. Y Intercept Hong Kong Ltd acquired a new position in shares of Teladoc Health during the second quarter worth approximately $2,722,000. Farther Finance Advisors LLC raised its position in Teladoc Health by 424.5% in the 2nd quarter. Farther Finance Advisors LLC now owns 9,960 shares of the health services provider’s stock worth $87,000 after purchasing an additional 8,061 shares during the last quarter. Ameritas Advisory Services LLC bought a new position in Teladoc Health in the 2nd quarter worth approximately $78,000. Wealth Management Associates Inc. acquired a new position in Teladoc Health during the 2nd quarter worth $509,000. Finally, Banco Bilbao Vizcaya Argentaria S.A. boosted its position in Teladoc Health by 23.1% in the 2nd quarter. Banco Bilbao Vizcaya Argentaria S.A. now owns 212,933 shares of the health services provider’s stock valued at $1,841,000 after buying an additional 39,956 shares during the last quarter. 76.82% of the stock is owned by institutional investors.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.